http://articles.cnn.com/2009-02-19/heal ... =PM:HEALTH
"The trials showed that
the drug extended the life of terminal patients by an average of four months, and in some cases several years, compared with those patients who only received traditional therapies. Younger patients tended to fare better.
"It has the potential to be very important," according to Dr. Howard Burris, director of drug development at the Sarah Cannon Research Institute in Nashville, Tennessee.
He said the results were comparable to those being produced by
two other lung cancer vaccines, GVAX and BLP 25, being developed in the United States.
"Larger trials will show there are subsets that it's very good for and for others it's not relevant," he said.
CimaVax EGF does not prevent or cure lung cancer. It is a therapeutic vaccine which stimulates the patient's body to make an antibody against the epidermal growth factor (EGF), which is a key driver causing lung cancer cells to grow.
It is used in conjunction with chemotherapy and radiation therapy which reduce the size of the initial tumor."
У каждого мальчишки должна быть собака - и мама, которая разрешит ему иметь собаку.